Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Jean Jacques Bienaime Insider Profile

11 Followers

Jean Jacques Bienaime, Director at Ascendis Pharma, holds 19.59K shares in Keros Therapeutics (Ticker: KROS), holds 2.90K shares in Ascendis Pharma (Ticker: ASND), holds 24.42K shares in Incyte (Ticker: INCY).

Jean Jacques Bienaime's Trading History

KROSKeros Therapeutics		Aug 19, 2026DirectorUninformative Buy10.27K$216.30K
ASNDAscendis Pharma		Aug 18, 2026DirectorInformative Buy492.65K$728.68K
INCYIncyte		Jun 10, 2026DirectorUninformative Buy―$2.94M
IMNMImmunome		Jun 09, 2026DirectorInformative Buy204.26K$790.59K
BMRNBioMarin Pharmaceutical		May 21, 2024DirectorUninformative Sell92.61K$42.20M
IMUXImmunic		Sep 24, 2018DirectorInformative Sell7.99K$138.94K
PTLAPortola Pharma		May 16, 2014―Informative Sell22.03K$12.73K
NGSXNeurogesx		Jul 26, 2011―Uninformative Buy19.18K$108.74
ITMNInterMune		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jean Jacques Bienaime insider profile FAQ

What is the percentage of profitable transactions made by Jean Jacques Bienaime?
The percentage of profitable transactions made by Jean Jacques Bienaime is 46%.
What is the average return per transaction made by Jean Jacques Bienaime?
The average return per transaction made by Jean Jacques Bienaime is 9.50%.
What stocks does Jean Jacques Bienaime hold?
Jean Jacques Bienaime holds: ASND, BMRN, KROS, IMNM, IMUX, INCY, PTLA, NGSX, ITMN stocks.
What was Jean Jacques Bienaime’s latest transaction?
Jean Jacques Bienaime’s latest transaction was an Uninformative Buy of $10.27K.
What was Jean Jacques Bienaime's most profitable transaction?
Jean Jacques Bienaime’s most profitable transaction was an Informative Buy of IMNM stock on March 25, 2025. The return on the trade was 192.00%.
What is Jean Jacques Bienaime's role in Ascendis Pharma?
Jean Jacques Bienaime's role in Ascendis Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.